Nice to see that after 4 months of treatment, patients are NOT experiencing serious side effects, which would be reason for DMC to pull the Phase 2 trial.
Now let's just hope in June/July (when interim results come out) we see improvements in efficacy.
Looks like there will still be a Phase 3 trial next year, but if Phase 2 results are exceptional, it might be a smaller trial?
Agree Scott, exciting times ahead IMO.
Nice to see that after 4 months of treatment, patients are NOT...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $23.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $17.8K | 3.6M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 66 | 75025101 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27379258 | 24 |
View Market Depth
| Last trade - 10.32am 27/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |